protein

Recombinant Human Apolipoprotein H Protein, CF

5087-AH-050

50 ug

373 USD

5087-AH

5087-AH-050

Recombinant Human Apolipoprotein H Protein, CF

The Recombinant Human Apolipoprotein H Protein, CF from R&D Systems is derived from NS0. The Recombinant Human Apolipoprotein H Protein, CF has been validated for the following applications: Bioactivity.

Apolipoprotein H/ApoH

50 ug

Proteins and Enzymes

Lyophilized from a 0.2 µm filtered solution in PBS.

Unconjugated

>95%, by SDS-PAGE under reducing conditions and visualized by silver stain

Human

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

57-60 kDa, reducing conditions

36.3 kDa

APOH

Measured by its binding ability in a functional ELISA. When recombinant human ApoH is immobilized at 2 µg/mL, 100 µL/well, the concentration of recombinant human LDL R (Catalog # 2148-LD) that produces 50% of the optimal binding response is found to be approximately 0.2 - 0.8 µg/mL.

<0.01 EU per 1 µg of the protein by the LAL method.

P02749

Bioactivity

5087-AH, rhApoH, hApoH, carrier-free, carrier free, 5O87-AH, 5087AH, ApolipoproteinH, ApoH, Apo-H, beta-2-glycoprotein I, Beta-2-glycoprotein 1 precursor, beta2-Glycoprotein 1, beta2-GPI, Anticardiolipin cofactor, APC inhibitor, Activated protein C- binding protein, heparin binding, antiphospholipid autoantibodies, antipho

NS0-derived Recombinant Human Apolipoprotein H Protein, CF

365

373 USD

Activated protein C-binding protein, Anticardiolipin cofactor, APC inhibitor, Apo-H, APOH, Apolipoprotein H, apolipoprotein H (beta-2-glycoprotein I), B2G1, B2GP1, B2GPI, Beta, Beta(2)GPI, beta-2-glycoprotein 1, Beta-2-glycoprotein I, BG